Sino Biopharmaceutical (OTCMKTS:SBMFF) Sees Significant Drop in Short Interest

Sino Biopharmaceutical (OTCMKTS:SBMFF) was the target of a significant decrease in short interest in the month of January. As of January 15th, there was short interest totaling 78,955,359 shares, a decrease of 25.1% from the December 31st total of 105,368,569 shares. Based on an average daily volume of 40 shares, the short-interest ratio is presently 1,973,884.0 days. Currently, 0.4% of the company’s shares are sold short. Currently, 0.4% of the company’s shares are sold short. Based on an average daily volume of 40 shares, the short-interest ratio is presently 1,973,884.0 days.

Sino Biopharmaceutical Stock Performance

Shares of Sino Biopharmaceutical stock opened at $0.83 on Tuesday. The company has a current ratio of 1.36, a quick ratio of 1.28 and a debt-to-equity ratio of 0.07. The stock has a 50 day moving average price of $0.88 and a 200-day moving average price of $0.94. Sino Biopharmaceutical has a one year low of $0.37 and a one year high of $1.24.

Sino Biopharmaceutical Company Profile

Sino Biopharmaceutical Limited (OTCMKTS: SBMFF) is a Hong Kong–incorporated investment holding company principally engaged in the pharmaceutical sector. Founded in 2000 and listed on the Hong Kong Stock Exchange in 2006, the company has developed an integrated business model that spans research and development, manufacturing and commercialization of healthcare products. Through its subsidiaries, Sino Biopharmaceutical focuses on enhancing China’s domestic pharmaceutical infrastructure while expanding its footprint across key therapeutic areas.

The company’s product portfolio is organized into three core segments: infusion solutions, small-molecule synthetic pharmaceuticals and innovative biologics.